Nature's Sunshine Products Inc. (NATR)

Price$19.90

Value ScoreB

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-13.82%

Price vs S&P 500 (4W)-24.55%

VGM Score56.67

Market Capitalization$368.93M

P/E Ratio (Annual)18.90x

All Metrics

P/CF (Annual)10.45x

Book Value / Share (Quarterly)$9.50

P/TBV (Annual)1.34x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)4.40%

Cash Flow / Share (Quarterly)$1.31

Price vs S&P 500 (YTD)-14.82%

Gross Margin (TTM)72.71%

Net Profit Margin (TTM)4.06%

EPS (TTM)$1.09

10-Day Avg Trading Volume0.14M

EPS Excl Extra (TTM)$1.09

Revenue Growth (5Y)4.50%

EPS (Annual)$1.06

ROI (Annual)12.08%

Gross Margin (Annual)72.42%

Net Profit Margin (5Y Avg)3.11%

Cash / Share (Quarterly)$4.99

P/E Basic Excl Extra (TTM)18.55x

Revenue Growth QoQ (YoY)8.52%

EPS Growth (5Y)-0.15%

P/E Normalized (Annual)18.90x

ROA (Last FY)7.48%

Revenue Growth TTM (YoY)7.26%

EBITD / Share (TTM)$2.28

ROE (5Y Avg)8.96%

Operating Margin (TTM)5.74%

Cash Flow / Share (Annual)$1.65

P/B Ratio2.21x

P/B Ratio (Quarterly)2.52x

Net Income / Employee (Annual)$24,200

EV / Revenue (TTM)0.57x

Net Interest Coverage (TTM)12.04x

ROA (TTM)7.63%

EPS Growth QoQ (YoY)13.34%

EV / EBITDA (TTM)6.75x

EPS Incl Extra (Annual)$1.06

Current Ratio (Annual)2.28x

Quick Ratio (Quarterly)1.40x

3-Month Avg Trading Volume0.12M

52-Week Price Return48.43%

EV / Free Cash Flow (Annual)9.76x

P/E Incl Extra (TTM)18.55x

Revenue / Employee (TTM)$607,700

Tangible BV / Share (Quarterly)$7.49

P/S Ratio (Annual)0.77x

Asset Turnover (Annual)1.84x

52-Week High$28.14

Operating Margin (5Y Avg)5.09%

EPS Excl Extra (Annual)$1.06

CapEx CAGR (5Y)5.71%

Tangible BV CAGR (5Y)0.65%

26-Week Price Return-0.24%

Quick Ratio (Annual)1.30x

13-Week Price Return-25.04%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.50x

Enterprise Value$281.35M

Revenue / Share Growth (5Y)6.18%

Asset Turnover (TTM)1.88x

Book Value / Share Growth (5Y)3.19%

Revenue / Employee (Annual)$595,700

Inventory Turnover (Annual)2.07x

Pretax Margin (Annual)6.21%

Cash / Share (Annual)$5.36

3-Month Return Std Dev35.77%

Gross Margin (5Y Avg)71.96%

Net Income / Employee (TTM)$24,700

EBITDA CAGR (5Y)3.66%

EBITDA Interim CAGR (5Y)4.31%

ROE (Last FY)12.08%

Net Interest Coverage (Annual)6.87x

EPS Basic Excl Extra (Annual)$1.06

P/FCF (TTM)12.79x

Receivables Turnover (TTM)40.88x

EV / Free Cash Flow (TTM)12.22x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$1.09

Receivables Turnover (Annual)53.12x

ROI (TTM)12.30%

P/S Ratio (TTM)0.75x

Pretax Margin (5Y Avg)5.12%

Revenue / Share (Annual)$26.00

Tangible BV / Share (Annual)$6.63

Forward P/E16.90x

Free OCF CAGR (5Y)-2.51%

Price vs S&P 500 (52W)20.28%

P/E Ratio (TTM)18.55x

EPS Growth TTM (YoY)103.36%

Year-to-Date Return-3.43%

5-Day Price Return-4.67%

EPS Normalized (Annual)$1.06

ROA (5Y Avg)5.54%

Net Profit Margin (Annual)4.07%

Month-to-Date Return-2.07%

Cash Flow / Share (TTM)$1.07

EBITD / Share (Annual)$2.09

EPS Growth (3Y)-34.26%

Operating Margin (Annual)5.15%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)11.95x

ROI (5Y Avg)8.90%

P/E Excl Extra (TTM)18.55x

LT Debt / Equity (Quarterly)0.01x

EPS Basic Excl Extra (TTM)$1.09

P/TBV (Quarterly)1.54x

P/B Ratio (Annual)2.34x

Inventory Turnover (TTM)2.02x

Pretax Margin (TTM)6.30%

Book Value / Share (Annual)$9.23

Price vs S&P 500 (13W)-35.70%

Net Margin Growth (5Y)-5.95%

Beta0.89x

P/FCF (Annual)12.79x

Revenue / Share (TTM)$27.32

ROE (TTM)12.30%

52-Week Low$12.97

vGradeB

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.30est. 0.23

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
NATRNature's Sunshine Products Inc.	B	C	C	$19.90
LLYEli Lilly & Co.	D	B	B	$1078.78
JNJJohnson & Johnson	C	C	C	$223.24
ABBVABBVIE INC.	D	C	C	$217.13
MRKMerck & Co., Inc.	C	C	C	$114.70
AZNAstraZeneca PLC	D	B	C	$176.28
NVSNovartis AG	C	C	C	$143.66
NVONovo-Nordisk A/S	B	B	B	$42.00
ABTAbbott Laboratories	C	C	D	$86.99
PFEPfizer Inc.	B	C	C	$25.34
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$32.83

About

Nature's Sunshine Products Inc manufactures and sells nutritional supplements and personal care products targeting weight management, cardiovascular health, digestive wellness, immune support, and general health. The company operates across Asia, Europe, North America, and Latin America, with Asia serving as its largest revenue market.